Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Pharma Industry News AbbVie makes bold move in Alzheimer’s market with $1.4bn Aliada buyout—Is it a gamble? AbbVie, the renowned American biopharmaceutical giant, is set to acquire Aliada Therapeutics for a staggering $1.4 billion. The… byPallavi MadhirajuOctober 28, 2024